Patents by Inventor Kang Ro Lee

Kang Ro Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140155609
    Abstract: The present invention relates to a novel quinoline derivative compound, an optical isomer thereof, a pharmaceutically acceptable salt thereof, and a hydrate or a solvate thereof. The novel quinoline derivative compound, the optical isomer thereof, the pharmaceutically acceptable salt thereof, and the hydrate or the solvate thereof accelerates gastrointestinal movement, and thus can effectively prevent or treat gastrointestinal motility disorders.
    Type: Application
    Filed: November 24, 2010
    Publication date: June 5, 2014
    Applicant: Dong-A ST Co., Ltd.
    Inventors: Miwon Son, Tae Ho Lee, Sang Zin Choi, Nam Joon Baek, Kang Ro Lee, Ki Hyun Kim, Soon Hoe Kim
  • Publication number: 20130317052
    Abstract: The present invention relates to a novel quinoline derivative compound, an optical isomer thereof, a pharmaceutically acceptable salt thereof, and a hydrate or a solvate thereof. The novel quinoline derivative compound, the optical isomer thereof, the pharmaceutically acceptable salt thereof, and the hydrate or the solvate thereof accelerates gastrointestinal movement, and thus can effectively prevent or treat gastrointestinal mobility disorders.
    Type: Application
    Filed: November 24, 2010
    Publication date: November 28, 2013
    Applicant: Dong-A ST Co., Ltd.
    Inventors: Miwon Son, Tae Ho Lee, Sang Zin Choi, Nam Joon Baek, Kang Ro Lee, Ki Hyun Kim, Soon Hoe Kim
  • Publication number: 20130296571
    Abstract: The present invention relates to a novel quinoline derivative compound, an optical isomer thereof, a pharmaceutically acceptable salt thereof, and a hydrate or a solvate thereof. The novel quinoline derivative compound, the optical isomer thereof, the pharmaceutically acceptable salt thereof, and the hydrate or the solvate thereof accelerates gastrointestinal movement, and thus can effectively prevent or treat gastrointestinal motility disorders.
    Type: Application
    Filed: November 24, 2010
    Publication date: November 7, 2013
    Applicant: Dong-A ST Co., Ltd.
    Inventors: Miwon Son, Tae Ho Lee, Sang Zin Choi, Nam Joon Baek, Kang Ro Lee, Ki Hyun Kim, Soon Hoe Kim
  • Patent number: 6255517
    Abstract: The present invention relates to a thymol derivative represented by following Chemical Formula 1, pharmaceutically acceptable salts or esters thereof, and anti-cancer agents comprising the same as an active ingredient.
    Type: Grant
    Filed: October 14, 1999
    Date of Patent: July 3, 2001
    Inventors: Ok Pyo Zee, Young Hoon Jung, Kang Ro Lee, Hyung In Moon, Hyung Geun Baek, Min Jung Lee, Dae Keun Kim